PCSK9 and acute monocytic leukemia: According to pre-clinical research, after silencing PCSK9 expression with siRNA, significant reduced IL-1α, IL-6, and TNF-α expression, as well as downregulated activation of the NF-κB pathway, were observed in human THP-1 (an acute monocytic leukemia cell line) cells [54].